PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VRTX vs. BMRN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

VRTX vs. BMRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vertex Pharmaceuticals Incorporated (VRTX) and BioMarin Pharmaceutical Inc. (BMRN). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%JuneJulyAugustSeptemberOctoberNovember
4.45%
-17.69%
VRTX
BMRN

Returns By Period

In the year-to-date period, VRTX achieves a 14.45% return, which is significantly higher than BMRN's -34.23% return. Over the past 10 years, VRTX has outperformed BMRN with an annualized return of 15.45%, while BMRN has yielded a comparatively lower -2.83% annualized return.


VRTX

YTD

14.45%

1M

-4.42%

6M

4.60%

1Y

35.77%

5Y (annualized)

17.32%

10Y (annualized)

15.45%

BMRN

YTD

-34.23%

1M

-9.54%

6M

-18.23%

1Y

-27.54%

5Y (annualized)

-4.00%

10Y (annualized)

-2.83%

Fundamentals


VRTXBMRN
Market Cap$126.19B$12.60B
EPS-$1.91$1.66
PEG Ratio1.320.42
Total Revenue (TTM)$10.61B$735.87B
Gross Profit (TTM)$9.14B$546.99B
EBITDA (TTM)-$147.50M$114.17B

Key characteristics


VRTXBMRN
Sharpe Ratio1.36-0.88
Sortino Ratio2.20-1.02
Omega Ratio1.280.84
Calmar Ratio2.79-0.47
Martin Ratio6.05-1.57
Ulcer Index5.51%17.28%
Daily Std Dev24.44%30.98%
Max Drawdown-91.77%-90.58%
Current Drawdown-9.88%-57.47%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.4

The correlation between VRTX and BMRN is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Risk-Adjusted Performance

VRTX vs. BMRN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vertex Pharmaceuticals Incorporated (VRTX) and BioMarin Pharmaceutical Inc. (BMRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VRTX, currently valued at 1.36, compared to the broader market-4.00-2.000.002.004.001.36-0.88
The chart of Sortino ratio for VRTX, currently valued at 2.20, compared to the broader market-4.00-2.000.002.004.002.20-1.02
The chart of Omega ratio for VRTX, currently valued at 1.28, compared to the broader market0.501.001.502.001.280.84
The chart of Calmar ratio for VRTX, currently valued at 2.79, compared to the broader market0.002.004.006.002.79-0.47
The chart of Martin ratio for VRTX, currently valued at 6.05, compared to the broader market0.0010.0020.0030.006.05-1.57
VRTX
BMRN

The current VRTX Sharpe Ratio is 1.36, which is higher than the BMRN Sharpe Ratio of -0.88. The chart below compares the historical Sharpe Ratios of VRTX and BMRN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
1.36
-0.88
VRTX
BMRN

Dividends

VRTX vs. BMRN - Dividend Comparison

Neither VRTX nor BMRN has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

VRTX vs. BMRN - Drawdown Comparison

The maximum VRTX drawdown since its inception was -91.77%, roughly equal to the maximum BMRN drawdown of -90.58%. Use the drawdown chart below to compare losses from any high point for VRTX and BMRN. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-9.88%
-57.47%
VRTX
BMRN

Volatility

VRTX vs. BMRN - Volatility Comparison

Vertex Pharmaceuticals Incorporated (VRTX) has a higher volatility of 9.96% compared to BioMarin Pharmaceutical Inc. (BMRN) at 6.67%. This indicates that VRTX's price experiences larger fluctuations and is considered to be riskier than BMRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
9.96%
6.67%
VRTX
BMRN

Financials

VRTX vs. BMRN - Financials Comparison

This section allows you to compare key financial metrics between Vertex Pharmaceuticals Incorporated and BioMarin Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items